InvestorsHub Logo
Followers 47
Posts 8777
Boards Moderated 0
Alias Born 04/10/2015

Re: None

Tuesday, 03/28/2017 12:08:15 PM

Tuesday, March 28, 2017 12:08:15 PM

Post# of 204
I might even buy more of this. The more I dig. The more it seems like a potential ROCKET: (CLINICAL STUDIES?)

Madison Ventures Inc., incorporated on September 14, 2009, focuses on development of products and devices for the treatment of anal fissures. The Company is engaged in licensing semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal fissure. The Company is also engaged in the production, use, import, offer for sale, sell, lease, distribute, or otherwise commercialize its technology for uses classified as medical devices, or those otherwise approved as an over-the-counter (OTC) remedy.
The device, which the Company intends to develop and market, is a medical foam wrapped with semi-occlusive wound dressing serving as a physical barrier to cover the anal fissure and maintain a moist physiological environment at the fissure lesion. The device is for one-time use and is provided in a kit with a set of 10 semi-occlusive wound dressings for 10-day treatment. The Company's activities in Israel are focused on advancement of clinical studies and production of product for use in clinical studies. The clinical studies are being carried out at the Wolfson Medical Centre in Israel and in the Hospital Sagrat Cor in Barcelona, Spain